Microsatellite-Stable Colorectal Cancer (MSS CRC) Shows Enrichment for Loss of Neoantigenic Mutations (NAMs) Compared to CRC with Microsatellite Instability (MSI)

被引：0
|
作者：
Nadhamuni, V. Srirangam [1 ]
Lakatos, E. [1 ]
Househam, J. [1 ]
Heide, T. [2 ]
Cresswell, G. [2 ]
Spiteri, I. [2 ]
Mossner, M. [1 ]
Kimberley, C. [1 ]
Ortiz, L. Zapata [2 ]
James, C. [2 ]
Lynn, C. [2 ]
Berner, A. [1 ]
Costa, H. [3 ]
Mitchinson, M. [3 ]
Jansen, M. [3 ]
Caravagna, G. [2 ,4 ]
Rodriguez-Justo, M. [3 ]
Shibata, D. [5 ]
Bridgewater, J. [3 ]
Baker, A-M [1 ]
Sottoriva, A. [2 ]
Graham, T. [1 ]
机构：
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] Inst Canc Res, London, England
[3] UCL, London, England
[4] Univ Trieste, Trieste, Italy
[5] Univ Southern Calif, Los Angeles, CA 90007 USA
来源：
JOURNAL OF PATHOLOGY | 2021年 / 255卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [31] A phase 2 study evaluating response and biomarkers in patients with microsatellite stable (MSS) advanced colorectal cancer (CRC) treated with nivolumab/relatlimab
    Christenson, Eric
    Durham, Jennifer N.
    Brancati, Madelena
    Bruning, Heather Davis
    Petrie, Susan
    Wang, Hao
    Lu, Jiayun
    Bever, Katherine M.
    Laheru, Dan
    De Jesus-Acosta, Ana
    Donehower, Ross C.
    Pishvaian, Michael J.
    Azad, Nilofer Saba
    Zhu, Qingfeng
    Llosa, Nicolas Jose
    Housseau, Franck
    Anders, Robert
    Pardoll, Drew M.
    Le, Dung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] A prospective blinded study of microsatellite instability (MSI) as a marker of overall survival (OS) in the adjuvant treatment of colorectal cancer (CRC) patients.
    Popat, S
    Pan, H
    Shao, Y
    Zhao, D
    Chen, Z
    Houlston, RS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 847S - 847S
  • [33] Prognostic value of microsatellite instability (MSI) and COX-2 expression in neoplastic tissue of patients with metastatic colorectal cancer (CRC) at diagnosis
    Ramus, Guido Vietti
    Coverlizza, Sergio
    Tonda, Laura
    Sirgiovanni, Marianna Paola
    De Marchi, Andrea
    ANNALS OF ONCOLOGY, 2005, 16 : 42 - 43
  • [34] Colorectal carcinoma (CRC) stage II: Evaluation of CDX2 expression and microsatellite instability (MSI) as potential biomarkers
    Pilozzi, E.
    Roberto, M.
    Quacquarini, D.
    Di Fede, L.
    Di Cerbo, A.
    Falcone, R.
    Vecchione, G.
    Marchetti, P.
    Ruco, L.
    Romiti, A.
    VIRCHOWS ARCHIV, 2017, 471 : S185 - S185
  • [35] Characterization of tumor mutation burden (TMB) and microsatellite instability (MSI) interplay for gastroesophageal adenocarcinoma (GA) and colorectal carcinoma (CRC).
    Huang, Xiu
    Tse, Julie Y.
    Protopopov, Alexei
    Russell, Meaghan
    Weeraratne, Dilhan
    Ring, Jennifer E.
    Bjonnes, Andrew
    Pei, Shermin
    Sun, Ruobai
    Lvova, Maria
    Li, Yajuan
    Lyle, Stephen
    Vuzman, Dana
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [36] Epidermal growth factor receptor (EGFR) overexpression and microsatellite instability in human colorectal cancer (CRC)?
    Aloulou, Nijez
    Chaumette, Marie Therese
    Abolhassani, Mohammad
    Sekour, Amel
    Leroy, Karen
    Sobhani, Iradj
    CANCER RESEARCH, 2006, 66 (08)
  • [37] NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability
    Wang, Hui
    Li, Zhi-Wei
    Ou, Qiuxiang
    Wu, Xue
    Nagasaka, Misako
    Shao, Yang
    Ou, Sai-Hong Ignatius
    Yang, Yu
    CANCER MEDICINE, 2022, 11 (13): : 2541 - 2549
  • [38] Association of PIK3CA mutations (mut) with immune engagement and clinical benefit from immunotherapy in microsatellite stable (MSS) colorectal cancer (CRC) patients (pts).
    Nusrat, Maliha
    Roszik, Jason
    Katkhuda, Riham
    Menter, David
    Raghav, Kanwal Pratap Singh
    Morris, Van K.
    Sharma, Padmanee
    Allison, James Patrick
    Blando, Jorge M.
    Maru, Dipen M.
    Lizee, Gregory
    Janku, Filip
    Overman, Michael J.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Discovering new drugs to target microsatellite instable (MSI) colorectal cancer (CRC) using the Connectivity Map (CMap)
    Vilar, E.
    Mukherjee, B.
    Rennert, G.
    Gruber, S. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Array CGH based DNA analysis specifies different genomic profiles in microsatellite instable (MSI) and microsatellite stable (MSS) colorectal cancer
    Dietmaier, Wolfgang
    Bettstetter, Marcus
    Weber, Elisabeth
    Radlwimmer, Bernhard
    Ferdinand, Peter Lichter
    Hofstaedter, Ferdinand
    CANCER RESEARCH, 2006, 66 (08)
12345